Persones / Equip Humà

Joana Claverol Torres

Buscador de publicacions

Publicacions

  • Dobaño C, Alonso S, Fernández de Sevilla-Estrach M, Vidal M, Jiménez A, Pons Tomas G, Jairoce C, Melé Casas M, Rubio R, Hernández García M, Ruiz-Olalla G, Girona M, Barrios D, Santano R, Mitchell RA, Puyol L, Mayer L, Chi J, Rodrigo Melero N, Carolis C, Garcia-Miquel A, Bonet-Carne E, Claverol J, Cubells M, Fortuny-Guasch C, Fumadó V, Jou-Munoz C, Munoz-Almagro C, Izquierdo L, Bassat Q, Gratacós E, Aguilar R, García-García JJ, Moncunill G and Jordán-García I.

    Antibody conversion rates to SARS-CoV-2 in saliva from children attending summer schools in Barcelona, Spain

    BMC MEDICINE . 19(1): 309-309. Nº de cites: 11

    [doi:10.1186/s12916-021-02184-1]

  • Brotons-de los Reyes P, Pérez-Argüello A, Launes-Montana C, FRANCESC TORRENTS GÓMEZ, Subirats MP, Saucedo-Verdes J, Claverol J, García-García JJ, Rodas G, Fumadó V, Jordán-García I, Gratacós E, Bassat Q and Munoz-Almagro C.

    Validation and implementation of a direct RT-qPCR method for rapid screening of SARS-CoV-2 infection by using non-invasive saliva samples

    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES . 110: 363-370. Nº de cites: 13

    [doi:10.1016/j.ijid.2021.07.054]

  • Brotons-de los Reyes P, Jordán-García I, Bassat Q, Henares-Bonilla D, Fernández de Sevilla-Estrach M, Ajanovic S, Redin-Alonso A, Fumadó V, Baro B, Claverol J, Varo R, Cuadras-Palleja D, Hecht J, Barrabeig I, García-García JJ, Launes-Montana C and Munoz-Almagro C.

    The Positive Rhinovirus/Enterovirus Detection and SARS-CoV-2 Persistence beyond the Acute Infection Phase: An Intra-Household Surveillance Study

    Viruses-Basel . 13(8): 1598. Nº de cites: 14

    [doi:10.3390/v13081598]

  • Alessandrini E, Brako F, Scarpa M, Lupo M, Bonifazi D, Pignataro V, Cavallo M, Cullufe O, Enache C, Nafria-Escalera B, Claverol J, De Taeye L, Vermeulen E, Preston J and Tuleu C.

    Children's Preferences for Oral Dosage Forms and Their Involvement in Formulation Research via EPTRI (European Paediatric Translational Research Infrastructure).

    Pharmaceutics . 13(5): 730. Nº de cites: 31

    [doi:10.3390/pharmaceutics13050730]

  • Turner M, Hildebrand H, Fernandes RM, de Wildt SN, Mahler F, Hankard R, Leary R, Bonifazi F, Nobels P, Cheng K, Attar S, Rossi P, Rocchi R, Claverol J, Nafria-Escalera B and Giaquinto C.

    The conect4children (c4c) Consortium: Potential for Improving European Clinical Research into Medicines for Children.

    Pharmaceutical Medicine . 35(2): 71-79. Nº de cites: 19

    [doi:10.1007/s40290-020-00373-6]

  • Tsang VWL, West L, Woods C, Koh CJ, McCune S, Mullin T, Smith SR, Gaillard S, Claverol J, Nafria-Escalera B, Preston J, Dicks P and Thompson C.

    Role of Patients and Parents in Pediatric Drug Development

    THERAPEUTIC INNOVATION & REGULATORY SCIENCE . 53(5): 601-608. Nº de cites: 14

    [doi:10.1177/2168479018820875]

  • Nordenmalm S, Kimland E, Ligas F, Lehmann B, Claverol J, Nafria-Escalera B, Tötterman AM and Pelle B.

    Children's views on taking medicines and participating in clinical trials

    ARCHIVES OF DISEASE IN CHILDHOOD . 104(9): 900-905. Nº de cites: 10

    [doi:10.1136/archdischild-2018-316511]

  • Pascual-Pastó G, Bazan-Peregrino M, Gene-Olaciregui N, Restrepo-Perdomo CA, Mato-Berciano A, Ottaviani D, Weber K, Correa MG, Paco-Mercader S, Vilà-Ubach M, Cuadrado-Vilanova M, Castillo H, Botteri G, García-Gerique L, Moreno-Gilabert H, Gimenez-Alejandre M, Alonso-Lopez P, Farrera-Sal M, Torres-Manjon S, Ramos-Lozano D, Moreno R, Aerts I, Doz F, Cassoux N, Chapeaublanc E, Torrebadell-Burriel M, Roldan-Molina M, König A, Suñol M, Claverol J, Lavarino C, de Torres C, Fu L, Radvanyi F, Munier FL, Català-Mora J, Mora J, Alemany R, Cascallo M, Chantada G and Carcaboso AM.

    Therapeutic targeting of the RB1 pathway in retinoblastoma with the oncolytic adenovirus VCN-01

    SCIENCE TRANSLATIONAL MEDICINE . 11(476): 9321. Nº de cites: 76

    [doi:10.1126/scitranslmed.aat9321]

  • Gaillard S, Malik S, Preston J, Nafria-Escalera B, Dicks P, Touil N, Mardirossian S, Claverol J and Kassai B.

    Involving children and young people in clinical research through the forum of a European Young Persons' Advisory Group: needs and challenges.

    FUNDAMENTAL & CLINICAL PHARMACOLOGY . 32(4): 357-362. Nº de cites: 34

    [doi:10.1111/fcp.12360]

  • Novák Z, Yáñez A, Kiss I, Kuna P, Tortajada-Girbés M and Valiente R.

    Safety and tolerability of bilastine 10 mg administered for 12 weeks in children with allergic diseases.

    PEDIATRIC ALLERGY AND IMMUNOLOGY . 27(5): 493-498. Nº de cites: 39

    [doi:10.1111/pai.12555]